Navigation Links
Three Teslas magnetic resonance imager acquired. Shot in the arm for research

The University Hospital at the University of Navarra and the Applied Medicine Research Centre (CIMA) of the University has purchased a 3 Teslas magnetic resonance// imager for use in research, being the first of its kind for research applications in Spain. The 3 Teslas is the magnetic resonance imaging unit, endowed with a superior capacity under the purview of the international medical bodies intended for the morphological study of the human body.

The University Hospital at the University of Navarra currently has two other magnetic resonance units. The first of these has strength of 0.2 Teslas (unit of magnetic field) with a C-shape or “open” structure. Apart from this, the hospital also has a 1.5 Teslas unit of a cylindrical shape.

The fundamental difference between the resonance units is marked by the intensity of the main magnetic field. There currently exist imaging units that have strengths from 0.2 Teslas and others that are currently in an experimental phase and reach a strength of 7 Teslas.

The most notable advantage of the 3 Teslas unit is its high precision given that it enables the recording of an enhanced image quality in less exploration time. Moreover, the imaging unit will be used to continue lines of research in close collaboration with CIMA, the most important of which involve the study of Alzheimer’s Disease and Parkinson’s.

Specialist medical uses

At a health care level, the medical specialities to benefit most from the acquisition of this unit, and in which the use is the most novel, are neuro-radiology, imaging diagnosis in muscular-skeletal injuries and angiography by Magnetic Resonance. Besides, there exist other areas of the body the study of which will also be enhanced by the use of 3 Teslas resonance such as the abdomen, the breast and the heart, amongst others.

Likewise, the greater strength of the magnetic field enables the optimisation of highly specialised techniqu es such as, for example, diffusion (used, fundamentally, for the study of the brain), perfusion (blood circulation system) and functional magnetic resonance.

Molecular radiology

The 3 Teslas unit also provides new care possibilities as regards molecular radiology. The new concept of imaging procedures involves the use of substances that are deposited at a molecular level and the behaviour of which, observed using various techniques, enables us to make a diagnosis and to differentiate the various elements under study. For example, the early diagnostic search for a cancer prior to it reaching a certain size. Side effects

Despite the overall innocuousness of the exploration and diagnostic technique, there are certain patients for which its use has side effects, basically those with pacemakers given that the magnetic fields render this heart apparatus inoperable. Any ferromagnetic metallic structures have to be carefully monitored before introducing a patient into a strong magnetic field, as the influence of the field may cause these metal structures to move or their temperature to rise.

Neuroimaging in Parkinson’s and Alzheimer

The acquisition of the 3 Teslas magnetic resonance imaging unit will enhance Functional Neuroimaging research – already initiated at the Applied Medicine Research Centre (CIMA) of the University.

A number of research projects into Parkinson’s disease focus on the role of the basal ganglia - altered with this condition - and the perception of tactile, auditory or visual stimuli. Within this line of research, one of the priority studies is related to the control of voluntary movement. For the patient with Parkinson’s, and using magnetic resonance, the areas of the brain that function while carrying out complex manual movements are identified and likewise how this cerebral activity is modified with learning. It is of interest to know the plasticity of these altered neuronal populations and how they react to and change with medication.

Another important line of research involves cognitive neurology, related to the onset of dementia. For example, in persons with memory or attention disorders, it can be determined if there exists incipient dementia or not. While undergoing resonance, the patient is given cognitive tasks of a simple nature and targeting a specific function, for example, attention, memory, orientation, discrimination, amongst others, with the aim of measuring the neuronal activity of the different parts of the patient’s brain while undertaking these cognitive tasks.

Source-Eurekaler
SAV
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Nobel Prize for Medicine shared by Three scientists
3. Three Tropical Parasites Genetic Code Unravelled
4. The Future Pattern Of Weight Gain Is Laid As Early As Three Years Of Age
5. Smoking Increases The Risk Of Heart Disease By Three Times
6. Three Sisters Have One Baby and Make History
7. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
8. Three More Bird Flu Cases Reported By China
9. Three meals daily Keeps Keralas elderly Healthy
10. Three dimensional structure of apolipoprotein revealed
11. Delhi Witnessed 34 Meningitis Deaths In Three Months
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: